2012-02-03 10:30:00 -

Biofrontera AG /
 /
Ad hoc: Biofrontera AG - 500,000 shares subscribed in capital increase
. Processed and transmitted by Thomson Reuters ONE.
The issuer is solely responsible for the content of this announcement. 

Leverkusen, 3 February 2012 - Management and supervisory board of Biofrontera AG
have decided to increase the company's base capital from EUR 11,240,486.00 by up
to Euro 500,000.00 to up to EUR 11,740,486.00 through issuing 500,000 new
ordinary shares from authorized capital II. The purchase right of the
shareholders was excluded. According to today's tabulation, the private
placement of the shares was successfully completed and over-subscribed. The
registration of the shares will follow shortly. The proceeds of the capital
increase amount to about € 1.5 mln.

Biofrontera AG, Hemmelrather Weg 201, 51377 Leverkusen
ISIN: DE0006046113
WKN: 604611

Contact:
Werner Pehlemann
Biofrontera AG
Tel.: +49 (0214)   87 63 20, Fax.: +49 (0214) 87 63 290
E-mail:w.pehlemann@biofrontera.com







This announcement is distributed by Thomson Reuters on behalf of 
Thomson Reuters clients. The owner of this announcement warrants that: 
(i) the releases contained herein are protected by copyright and 
    other applicable laws; and 
(ii) they are solely responsible for the content, accuracy and 
     originality of the information contained therein. 
    
Source: Biofrontera AG via Thomson Reuters ONE

[HUG#1582430]